Antibiotic-induced endotoxin release is organism-dependent in experimental gram-negative sepsis

Journal of Endotoxin Research

Volumn 4, Issue 5, 1997, Pages 315-323

  Healy, D P ^a   Clendening, C E ^a   Neely, A N ^a   Holder, I A ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFTAZIDIME; CIPROFLOXACIN; ENDOTOXIN; GENTAMICIN; IMIPENEM; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BURN; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE SEPSIS; IMMUNE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; KLEBSIELLA PNEUMONIAE; LIMULUS LYSATE TEST; MEDIATOR RELEASE; MOUSE; NONHUMAN; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA;

ANIMALIA; BACILLI; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; LIMULUS; MIRABILIS; NEGIBACTERIA; PROTEUS MIRABILIS; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 0031435913     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1177/096805199700400502     Document Type: Article

References (37)

1. Hurley J.C. Antibiotic-induced release of endotoxin: a reappraisal. Clin Infect Dis 1992; 15: 840-854.
2. Prins J.M., van Deventer S.J.H., Kuijper E.J., Speelman P. Clinical relevance of antibiotic-induced endotoxin release. Antimicrob Agents Chemother 1994; 38: 1211-1218.
3. Prins J.M. Antibiotic induced release of endotoxin - clinical data and human studies. J Endotoxin Res 1996; 3: 269-273.
4. Bucklin S.E., Morrison D.C Differences in therapeutic efficacy among cell wall-active antibiotics in a mouse model of Gram-negative sepsis. J Infect Dis 1995; 172: 1519-1527.
5. Bucklin S.E., Fujihara Y., Leeson M.C., Morrison D.C. Differential antibiotic-induced release of endotoxin from gram-negative bacteria. Eur J Clin Microbiol Infect Dis 1994; 13 (Suppl. 1): 43-51.
6. Goto H., Nakamura S. Liberation of endotoxin from E. coli by addition of antibiotics. Japan J Exp Med 1980; 50: 35-43.
7. Cooperstock M.S. Inactivation of endotoxin by polymyxin B. Antimicrob Agents Chemother 1974; 6: 422-425.
8. Jackson J.J., Kropp H. β-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime. J Infect Dis 1992; 165: 1033-1041.
9. Jackson J.J., Kropp H. Differences in mode of action and β-lactam antibiotics influence morphology, LPS release and in vivo antibiotic efficacy. J Endotoxin Res 1996; 3: 201-218.
10. Shenep J.L., Barton R.P., Mogan K.A. Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental Gram-negative bacterial sepsis. J Infect Dis 1985; 151: 1012-1018.
11. Dofferhoff A.S.M., Nijland J.H., de Vries-Hospers H.G., Mulder P.O.M., Weits J., Bom V.J.J. Effects of different types and combinations of antimicrobial agents on endotoxin release from Gram negative bacteria: an in vitro and in vivo study. Scand J Infect Dis 1991; 23: 745-754.
12. Shenep J.L., Mogan K.A. Kinetics of endotoxin release during antibiotic therapy for experimental Gram-negative bacterial sepsis. J Infect Dis 1984; 150: 380-388.
13. Dofferhoff A.S.M., Potthoff H., Bom V.J.J. et al. The release of endotoxin, TNF and IL-6 during the antibiotic treatment of experimental Gram-negative sepsis. J Endotoxin Res 1995; 2: 37-44.
14. Healy D.P., Verst-Brasch C.L., Clendening C.E., Neely A.N., Holder I.A. Kinetics of endotoxin and interleukin-6 following multiple doses of antibiotics for experimental Gram-negative bacterial sepsis. J Endotoxin Res 1996; 3: 93-101.
15. Healy D.P., Verst-Brasch C.L., Clendening C.E., Neely A.N., Holder I.A. Influence of drug class and dose size on antibiotic-induced endotoxin/IL-6 release and impact on efficacy of anti-endotoxin antibody. J Endotoxin Res 1996; 3: 219-227.
16. McConnell J.S., Cohen J. Release of endotoxin from Escherichia coli by quinolones. J Antimicrob Chemother 1986; 18: 765-773.
17. Van den Berg C., De Neeling A.J., Schot C.S., Hustinx W.N.M., Wemer J., De Wildt D.J. Delayed antibiotic-induced lysis of Escherichia coli in vitro is correlated with enhancement of LPS release. Scand J Infect Dis 1992; 24: 619-627.
18. Evans M.E., Pollack M. Effect of antibiotic class and concentration on the release of lipopolysaccharide from Escherichia coli. J Infect Dis 1993; 167: 1336-1343.
19. Eng R.H.K., Smith S.M., Fan-Havard P., Ogbara T. Effect of antibiotics on endotoxin release from Gram-negative bacteria. Diagn Microbiol Infect Dis 1993; 16: 185-189.
20. Crosby H.A., Bion J.F., Penn C.W., Elliott T.S.J. Antibiotic-induced release of endotoxin from bacteria in vitro. J Med Microbiol 1994; 40: 23-30.
21. Lamp K.C., Rybak M.J., McGrath B.J., Summers K.K. Influence of antibiotic and E5 monoclonal immunoglobulin M interactions on endotoxin release from Escherichia coli and Pseudomonas aeruginosa. Antimicrob Agents Chemother 1996; 40: 247-252.
22. Opal S.M., Horn D.L., Palardy J.E. et al. The in vivo significance of antibiotic-induced endotoxin release in experimental Gram-negative sepsis. J Endotoxin Res 1996; 3: 245-252.
23. Stieritz D.D., Holder I.A. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model. J Infect Dis 1975; 131: 688-691.
24. Neely A.N., Holder I.A. A murine model with aspects of clinical relevance for the study of antibiotic-induced endotoxin release in septic hosts. J Endotoxin Res 1996; 3: 229-235.
25. Neely A.N., Miller R.G., Holder I.A. Proteolytic activity and fatal Gram negative sepsis in burned mice: effect of exogenous proteinase inhibitor. Infect Immun 1994; 62: 2158-2164.
26. Long W.M., Sprung C.L. Corticosteroids, nonsteroidal anti-inflammatory drugs, and naloxone in sepsis syndrome. World J Surg 1987; 11: 218-225.
27. Sibinga N., Goldstein A. Opioid peptides and opioid receptors in the cells of the immune system. Annu Rev Immunol 1988; 6: 219-249.
28. Hurley J.C. Endotoxemia: methods of detection and clinical correlates. Clin Microbiol Rev 1995; 8: 268-292.
29. Kusser W.C., Ishiguro E.E. Effects of aminoglycosides and spectinomycin on the synthesis and release of lipopolysaccharide by Escherichia coli. Antimicrob Agents Chemother 1988; 32: 1247-1250.
30. Artenstein A.W., Cross A.S. Inhibition of endotoxin reactivity by aminoglycosides. J Antimicrob Chemother 1989; 24: 826-828.
31. Prins J.M., van Agtmael M.A., Kuijper E.J., van Deventer S.J.H., Speelman P. Antibiotic-induced endotoxin release in patients with Gram-negative urosepsis: a double-blind study comparing imipenem and ceftazidime. J Infect Dis 1995; 172: 886-891.
32. Dofferhoff A.S.M., Bom V.J.J., de Vries-Hospers H.G. et al. Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute-phase proteins during the treatment of severe sepsis in humans. Crit Care Med 1992; 20: 185-192.
33. Calandra T., Gerain J., Heumann D. et al. High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. Am J Med 1991; 91: 23-29.
34. Damas P., Ledoux D., Nys M. et al. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg 1992; 215: 356-362.
35. Holzheimer R.G., Hirte J.F., Reith B. et al. Different endotoxin release and IL-6 plasma levels after antibiotic administration in surgical intensive care patients. J Endotoxin Res 1996; 3: 261-267.
36. Rietschel E.T., Schade U., Jensen M. et al. Bacterial endotoxin: chemical structure, biological activity and role in septicaemia. Scand J Infect Dis 1982; 31 (Suppl): 8-21.
37. Brandenburg K., Seydel U., Schromm A.B., Loppnow H., Koch M.H.J., Rietschel E.T. Conformation of lipid A, the endotoxin center of bacterial lipopolysaccharide. J Endotoxin Res 1996; 3: 173-178.